Clarification

09/30/2004

Due to a lack of clarity in the original news report, a summary in Monday's FDLI SmartBrief stated that Purdue Pharma said Palladone, its recently approved analgesic, may be more difficult to misuse than OxyContin. Purdue Pharma says it does not claim that Palladone, which has been approved by the FDA, is abuse-resistant or more difficult to misuse than OxyContin.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL